Evidence map›Paper›PMID 15654825›Full record

ArticleClinical and experimental immunology2005

Analysis of the susceptibility of CD57 T cells to CD3-mediated apoptosis.

N Shinomiya, Y Koike, H Koyama, E Takayama, Y Habu, M Fukasawa, S Tanuma, S Seki

Open access · bronzeAbstract read
In one paragraph

Article in Clinical and experimental immunology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

N ShinomiyaDepartment of Microbiology, National Defense Medical College, Tokorozawa, Japan.
Y Koike
H Koyama
E Takayama
Y Habu
M Fukasawa
S Tanuma
S Seki
Tokyo University of Science · JPNational Defense Medical College · JPPediatrics and Genetics · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

After stimulation with anti-CD3 antibody in vitro, CD57(+) T cells showed a greater susceptibility to apoptosis than CD57(-)alphabetaT cell receptor (TCR)(+) T cells (regular alphabeta T cells). The apoptotic fraction of CD57(+) T cells showed an increased production of active caspase-3. An increase in both Fas expression and Fas-ligand (FasL) production was also observed in CD57(+) T cells, whereas the expression of survivin was suppressed in CD57(+) T cells compared to that of regular alphabeta T cells. CD57(+) T cells display a biased expansion of a few Vbeta T cell fractions in individuals, but such Vbeta T cells were not specifically susceptible to CD3-mediated apoptosis. The TCR expression level of CD57(+) T cells was much lower than that of regular T cells and anti-TCR antibody stimulation induced a smaller apoptotic proportion of CD57(+) T cells than did anti-CD3 antibody. Although the CD3epsilon expression levels were similar in both T cell subsets, the CD3zeta level of CD57(+) T cells was significantly higher than that of regular T cells. These results suggest that several apoptotic and anti-apoptotic molecules are involved in the CD3-induced apoptosis of CD57(+) T cells and raise the possibility that the imbalance in expression of the CD3epsilon and CD3zeta chains may also contribute to the susceptibility of CD57(+) T cells to undergo apoptosis.

Indexed as

AdultAntibodiesApoptosisCaspase 3CaspasesCD3 ComplexCD57 AntigensCells, CulturedFas Ligand Proteinfas ReceptorHumansImmunoglobulin epsilon-ChainsImmunoglobulin gamma-ChainsInhibitor of Apoptosis ProteinsMembrane GlycoproteinsMicrotubule-Associated ProteinsAntibodiesBIRC5 protein, humanCASP3 protein, humanCaspase 3CaspasesCD3 ComplexCD57 AntigensFASLG protein, humanFas Ligand Proteinfas ReceptorImmunoglobulin epsilon-ChainsImmunoglobulin gamma-ChainsInhibitor of Apoptosis ProteinsMembrane GlycoproteinsMicrotubule-Associated ProteinsNeoplasm ProteinsReceptors, Antigen, T-Cell, alpha-betaSurvivin

Identifiers

PMID15654825
PMCPMC1809296
OpenAlexW2007792198

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.